35zn: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "35zn": Seeded page ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
The entry 35zn is ON HOLD | The entry 35zn is ON HOLD until Paper Publication | ||
Authors: Biehl, S., Mateus, S., Maganathan, N., Norris, J., Broni, E., Zak, D., Fink, E., Young, K., Hancock, G., Miller, W., McDonnell, D.P., Willson, T., Fanning, S.W. | Authors: Biehl, S., Mateus, S., Maganathan, N., Norris, J., Broni, E., Zak, D., Fink, E., Young, K., Hancock, G., Miller, W., McDonnell, D.P., Willson, T., Fanning, S.W. | ||
| Line 7: | Line 7: | ||
Description: Estrogen Receptor Alpha Ligand Binding Domain in Complex with 2-{6-Chloro-3-[m-(2-cyclopropylethoxy)phenyl]-1-thia-5,7-diaza-4-indenyl}-5-isoindolinol | Description: Estrogen Receptor Alpha Ligand Binding Domain in Complex with 2-{6-Chloro-3-[m-(2-cyclopropylethoxy)phenyl]-1-thia-5,7-diaza-4-indenyl}-5-isoindolinol | ||
[[Category: Unreleased Structures]] | [[Category: Unreleased Structures]] | ||
[[Category: | [[Category: Maganathan, N]] | ||
[[Category: Norris, J]] | |||
[[Category: Fanning, S.W]] | [[Category: Fanning, S.W]] | ||
[[Category: Biehl, S]] | |||
[[Category: Zak, D]] | |||
[[Category: Mateus, S]] | |||
[[Category: Mcdonnell, D.P]] | [[Category: Mcdonnell, D.P]] | ||
[[Category: Hancock, G]] | |||
[[Category: Young, K]] | |||
[[Category: Miller, W]] | [[Category: Miller, W]] | ||
[[Category: Willson, T]] | [[Category: Willson, T]] | ||
[[Category: Broni, E]] | [[Category: Broni, E]] | ||
[[Category: Fink, E]] | [[Category: Fink, E]] | ||
Latest revision as of 12:17, 1 July 2026
Unreleased structure
The entry 35zn is ON HOLD until Paper Publication
Authors: Biehl, S., Mateus, S., Maganathan, N., Norris, J., Broni, E., Zak, D., Fink, E., Young, K., Hancock, G., Miller, W., McDonnell, D.P., Willson, T., Fanning, S.W.
Description: Estrogen Receptor Alpha Ligand Binding Domain in Complex with 2-{6-Chloro-3-[m-(2-cyclopropylethoxy)phenyl]-1-thia-5,7-diaza-4-indenyl}-5-isoindolinol
